Drug intelligence / Profile preview

Decoquinate

Development stage
Unknown
Lead developer
Phibro Animal Health
Modality
Small Molecules
Administration
Oral
01

Overview

Decoquinate is a quinolone derivative primarily utilized as an anticoccidial agent in veterinary medicine. It is effective in the prevention and control of coccidiosis, a parasitic disease caused by protozoans of the genus *Eimeria* in various livestock, including poultry, cattle, sheep, and goats. Its mechanism of action involves inhibiting mitochondrial oxygen consumption and electron transport within the parasites, specifically targeting sporozoites and first-generation schizonts, thereby disrupting their energy metabolism and preventing their development and reproduction. Decoquinate is typically administered orally as a medicated feed additive. While primarily a veterinary drug, it has also been investigated for potential applications in human medicine, particularly against parasitic infections like malaria, although its high lipophilicity and low aqueous solubility present challenges for human absorption.

Brand names
DeccoxDeccox-M
Other names
6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylic acid ethyl esterEthyl 6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylateEthyl6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylateEthyl-6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylate
02

Targets

bc1 complex (Cytochrome bc1 complex (plasmodium))

Beyond the preview

Go deeper on Decoquinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decoquinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call